Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: February 28, 2005
Last updated: April 15, 2015
Last verified: April 2015